GlassScriptPhysician profile
Arul Velavan Chandran
NPI 1821304338
$8,769.36
in general payments reported to CMS, 2019-2025
33 companies · $7,014 in 2025
The $7,014 reported for 2025 was more than what 91% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $402 · 2020: $93.85 · 2021: $101 · 2022: $310 · 2023: $320 · 2024: $529 · 2025: $7,014.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Food and Beverage: $1,543 · Travel and Lodging: $820.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Food and Beverage | $1,543.28 |
| Travel and Lodging | $819.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,336.64 | 2025 | |
| Glaxosmithkline, LLC. | $461.94 | 2019-2025 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $259.86 | 2019-2025 | Airsupra, Fasenra, Tezspire |
| Amgen INC. | $199.91 | 2022-2025 | Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $189.82 | 2020-2025 | Ofev, Jascayd |
| Actelion Pharmaceuticals US, INC. | $149.19 | 2019-2025 | Opsumit |
| Regeneron Healthcare Solutions, INC. | $137.40 | 2019-2024 | Dupixent |
| Harmony Biosciences LLC | $126.22 | 2024-2025 | |
| Inspire Medical Systems, INC. | $102.09 | 2024 | Inspire |
| Genzyme Corporation | $96.68 | 2022-2025 | |
| Mylan Specialty L.P. | $70.88 | 2019-2022 | |
| Resmed Corp | $65.26 | 2023-2025 | |
| Lilly USA, LLC | $60.40 | 2025 | Zepbound |
| Merck Sharp & Dohme LLC | $55.37 | 2019-2025 | Zerbaxa, Winrevair |
| Tactile Systems Technology INC | $44.34 | 2023-2025 | Flexitouch Plus, Nimbl, Entre Plus |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $42.99 | 2024-2025 | Glassia |
| Pfizer INC. | $41.10 | 2025 | |
| Grifols USA, LLC | $37.78 | 2019-2023 | Prolastin-C Liquid |
| Mallinckrodt Hospital Products INC. | $34.19 | 2020-2022 | |
| Jazz Pharmaceuticals INC. | $29.60 | 2021-2024 | |
| Baxter Healthcare | $28.66 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Pulmonx Corporation | $28.04 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.98 | 2024 | |
| Sunovion Pharmaceuticals INC. | $19.86 | 2019 | |
| Alexion Pharmaceuticals, INC. | $18.32 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $15.54 | 2019 | |
| Inogen, INC. | $15.14 | 2022 | |
| Inari Medical, INC. | $14.95 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Verona Pharma, INC. | $14.66 | 2025 | Ohtuvayre |
| Allergan, INC. | $14.36 | 2019 | |
| Gilead Sciences, INC. | $13.37 | 2021 | |
| Mallinckrodt Enterprises LLC | $12.42 | 2019 | |
| Bard Access Systems, INC. | $12.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arul Chandran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.